GSK-3 as a therapeutic target of lithium

被引：0
|
作者：
Klein, P. S. [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
    Jope, RS
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) : 441 - 443
  • [42] The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
    Augello, Giuseppa
    Emma, Maria R.
    Cusimano, Antonella
    Azzolina, Antonina
    Montalto, Giuseppe
    McCubrey, James A.
    Cervello, Melchiorre
    CELLS, 2020, 9 (06) : 1 - 17
  • [43] Lack of effect of mood stabilizers or neuroleptics on GSK-3β protein levels and GSK-3 activity
    Kozlovsky, N
    Nadri, C
    Belmaker, RH
    Agam, G
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (02): : 117 - 120
  • [44] N-terminal cleavage of GSK-3 by calpain -: A new form of GSK-3 regulation
    Goni-Oliver, Paloma
    Lucas, Jose J.
    Avila, Jesus
    Hernandez, Felix
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (31) : 22406 - 22413
  • [45] Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells
    Jia, Qi
    Tao, Li
    Zhou, Yinyin
    Song, Li
    Wei, Zhonghong
    Lu, Tao
    Woodgett, James R.
    Lu, Yin
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 106 (03) : 170 - 180
  • [46] Validating GSK3 as an in vivo target of lithium action
    O'Brien, W. Timothy
    Klein, Peter S.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 : 1133 - 1138
  • [47] GSK3 as a pathogenic kinase in tauopathy and the use of GSK3 inhibitors such as Lithium as a therapeutic
    Duff, Karen
    Planel, Emmanuel
    Noble, Wendy
    MOVEMENT DISORDERS, 2008, 23 (08) : 1197 - 1197
  • [48] GSK3-beta as a therapeutic target in bladder cancer
    Becker, Marie N.
    von Roemeling, Christina A.
    Copland, John A.
    Williams, Christopher R.
    CANCER RESEARCH, 2011, 71
  • [49] GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors?
    Prada, Elke Tatjana Aristizabal
    Weis, Carla
    Orth, Michael
    Lauseker, Michael
    Spoettl, Gerald
    Maurer, Julian
    Grabowski, Patricia
    Grossman, Ashley
    Auernhammer, Christoph Josef
    Noelting, Svenja
    NEUROENDOCRINOLOGY, 2018, 106 (04) : 335 - 351
  • [50] Evaluation of the Association between Lithium Treatment and GSK-3β Polymorphism in Bipolar Disorder Patients
    Altinbas, Kursat
    Yesilbas, Dilek
    Ince, Bahri
    Cansiz, Alparslan
    Silan, Fatma
    Ozdemir, Ozturk
    Guloksuz, Sinan
    TURK PSIKIYATRI DERGISI, 2018, 29 (02) : 73 - 78
12345